retatrutide type 2 diabetes trial 2024 ESC 2024: improves lipid and cardiovascular risk profile in Phase II 💉 A triple-action once-weekly injection

The effect of tirzepatide was compared to wild-type obese and GLP- 1 receptor-null mice to determine whether GIP receptor agonism plays a role

Ensure that your diet includes sufficient lean protein sources like chicken, fish, tofu, and legumes to support muscle retention and metabolism

Functional status was also found to be more highly correlated with perceived HRQL than symptom burden

Mearns ES, Saulsberry WJ, White CM et al (2015) Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in type 2 diabetes: a network meta-analysis

Benefit-risk profile As the research on retatrutide continues to evolve, healthcare providers and individuals considering this treatment option can expect a deeper understanding of the medications side effect profile

Patients who have plateaued on a previous medication are candidates for the next step up